A team from the Universitat Politècnica de València (UPV), the Universitat de València (UV), and the Centro de Investigación Biomédica en Red sobre Enfermedades Raras (CIBERER) has developed a lateral ...
Scientists and public health experts built the COVID-19 pandemic response on years of experience navigating infectious disease outbreaks. Although lateral flow immunoassays have been central to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback